Graham FL - Search Results

1

A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma.

Stewart AK, Lassam NJ, Graham FL, Gauldie J, Addison CL, Bailey DJ, Dessureault S, Dubé ID, Gallenger S, Krajden M, Rotstein LE, Quirt IC, Moen R. Stewart AK, et al. Among authors: graham fl. Hum Gene Ther. 1997 Jul 20;8(11):1403-14. doi: 10.1089/hum.1997.8.11-1403. Hum Gene Ther. 1997. PMID: 9295135 Clinical Trial. No abstract available.

2

Intramarrow cytokine gene transfer by adenoviral vectors in dogs.

Foley R, Ellis R, Walker I, Wan Y, Carter R, Boyle M, Braciak T, Addison C, Graham F, Gauldie J. Foley R, et al. Hum Gene Ther. 1997 Mar 20;8(5):545-53. doi: 10.1089/hum.1997.8.5-545. Hum Gene Ther. 1997. PMID: 9095406

3

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination.

Wan Y, Bramson J, Carter R, Graham F, Gauldie J. Wan Y, et al. Hum Gene Ther. 1997 Jul 20;8(11):1355-63. doi: 10.1089/hum.1997.8.11-1355. Hum Gene Ther. 1997. PMID: 9295130

4

Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12.

Bramson JL, Hitt M, Addison CL, Muller WJ, Gauldie J, Graham FL. Bramson JL, et al. Among authors: graham fl. Hum Gene Ther. 1996 Oct 20;7(16):1995-2002. doi: 10.1089/hum.1996.7.16-1995. Hum Gene Ther. 1996. PMID: 8930660

5

Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia.

Xing Z, Ohkawara Y, Jordana M, Graham FL, Gauldie J. Xing Z, et al. Among authors: graham fl. Gene Ther. 1997 Feb;4(2):140-9. doi: 10.1038/sj.gt.3300371. Gene Ther. 1997. PMID: 9081704

6

Human adenovirus vectors for gene transfer into mammalian cells.

Hitt MM, Addison CL, Graham FL. Hitt MM, et al. Among authors: graham fl. Adv Pharmacol. 1997;40:137-206. doi: 10.1016/s1054-3589(08)60140-4. Adv Pharmacol. 1997. PMID: 9217926 Review. No abstract available.

7

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.

Bramson JL, Hitt M, Gauldie J, Graham FL. Bramson JL, et al. Among authors: graham fl. Gene Ther. 1997 Oct;4(10):1069-76. doi: 10.1038/sj.gt.3300508. Gene Ther. 1997. PMID: 9415313

8

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNF alpha.

Marr RA, Addison CL, Snider D, Muller WJ, Gauldie J, Graham FL. Marr RA, et al. Among authors: graham fl. Gene Ther. 1997 Nov;4(11):1181-8. doi: 10.1038/sj.gt.3300528. Gene Ther. 1997. PMID: 9425441

9

Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer.

Pützer BM, Bramson JL, Addison CL, Hitt M, Siegel PM, Muller WJ, Graham FL. Pützer BM, et al. Among authors: graham fl. Hum Gene Ther. 1998 Mar 20;9(5):707-18. doi: 10.1089/hum.1998.9.5-707. Hum Gene Ther. 1998. PMID: 9551618

10

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.

Addison CL, Bramson JL, Hitt MM, Muller WJ, Gauldie J, Graham FL. Addison CL, et al. Among authors: graham fl. Gene Ther. 1998 Oct;5(10):1400-9. doi: 10.1038/sj.gt.3300731. Gene Ther. 1998. PMID: 9930346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page